تحليلات المنتج الاختيارية
بإذنك، نستخدم تحليلات محدودة تراعي الخصوصية لفهم مسارات البحث الفعالة. لا نستخدم أدوات تتبع إعلانية أو تسجيل الجلسات. يمكنك تغيير هذا الخيار في التفضيلات. اقرأ سياسة الخصوصية.
Ecolab Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $76.7B | |
|---|---|---|
| Revenue (ttm) | 17.4B | |
| Net income (ttm) | 2.1B | |
| EPS (ttm) | $7.35 | |
| Shares out | 280.3M | |
| P/E (trailing) | 39.8x | |
| P/E (forward) | 29.7x | |
| Dividend | $2.92 (1.00%) | |
| Volume | 889,192 | |
| Beta | 0.88 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $12.73B | $14.19B | $15.32B | $15.74B | $16.08B | +6.0% |
| Gross profit | $5.22B | $5.42B | $6.18B | $6.84B | $7.16B | +8.2% |
| Operating income | $1.60B | $1.56B | $1.99B | $2.80B | $2.74B | +14.4% |
| Net income | $1.13B | $1.09B | $1.37B | $2.11B | $2.08B | +16.4% |
| EPS (diluted) | $3.91 | $3.81 | $4.79 | $7.37 | $7.28 | +16.8% |
| EBITDA | $2.47B | $2.55B | $3.03B | $3.85B | $3.46B | +8.8% |
| R&D | $186.0M | $190.0M | $192.0M | $207.0M | $202.0M | +2.1% |
| SG&A | $3.42B | $3.65B | $4.06B | $4.23B | $4.26B | +5.7% |
Recent company headlines from major financial publishers.
Ecolab executes cleanly on its core operational targets: Water Services preserves steady consumable pricing and volume replenishment, operating margins expand toward guided targets, and China debottlenecking supports steady bioprocessing demand. However, even under this successful operating performance, fundamental cash flows yield Fair value of $203.99, indicating that shares at $273.70 reflect an implied return of -25.5%.
Rapid commercial scaling of CoolIT liquid cooling systems across AI data centers multiplies addressable sales opportunities 3x to 5x, while China purification debottlenecking sustains double-digit life sciences growth toward a 30% ROI. Value pricing overcomes raw material inflation rapidly within three months, accelerating operating margin expansion beyond 20% and driving valuation toward the upper fair value boundary of $251.65.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 8.0% | $219 | $223 | $227 | $232 | $237 |
| 8.5% | $208 | $211 | $215 | $218 | $223 |
| 9.0% | $198 | $201 | $204 | $207 | $211 |
| 9.5% | $190 | $193 | $195 | $198 | $200 |
| 10.0% | $183 | $185 | $187 | $189 | $192 |
Upcoming earnings date and setup when available.
التصنيف الذي حملته نسخة البحث المنشورة في كل شهر. يقارن التصنيف السعر في تاريخ التحليل بالقيمة العادلة، وليس سجلاً لمدى صحة التقدير.
| السنة | يناير | فبراير | مارس | أبريل | مايو | يونيو | يوليو | أغسطس | سبتمبر | أكتوبر | نوفمبر | ديسمبر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
